Atriva receives FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections
10.01.2022 Atriva receives FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections | Atriva Therapeutics | FDA ODD
Source: dgap.de
Stay updated with breaking news from Da Odd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10.01.2022 Atriva receives FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections | Atriva Therapeutics | FDA ODD